Cytek Biosciences, Inc. CTKB Service — Total revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s service — total revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s service — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported service — total revenue, net of $15.36M in Q1 2026.
- How has Cytek Biosciences, Inc.'s service — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s service — total revenue, net increased by 15.1% year-over-year, from $13.35M to $15.36M.
- What is the long-term trend for Cytek Biosciences, Inc.'s service — total revenue, net?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s service — total revenue, net has grown at a 61.4% compound annual growth rate (CAGR), from $8.43M to $57.26M.
- What does service — total revenue, net mean?
- This metric represents the total net revenue generated from service-related activities, including maintenance contracts, instrument repairs, and technical support. It reflects the company's ability to monetize its installed base of analytical instruments through recurring service agreements and on-demand support. Growth in this area indicates increasing customer adoption and long-term reliance on the company's technology ecosystem.